Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study was to examine whether electrical impedance tomography (EIT) was capable of identifying the deteriorated lung function on a regional level during bronchial challenge testing and whether EIT may provide additional information during bronchial challenge testing and identify spatial and temporal heterogeneity of regional lung function.
The content of this study includes:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| global inhomogeneity index (GI) | Measured by EIT, used to describe the overall degree of spatial heterogeneity of ventilation. | 1day |
| forced expiratory volume in 1s (FEV1) | The forced expiratory volume in 1s measured during pulmonary function tests. | 1day |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
1. patients with a pre-bronchodilator FEV1≤60% predicted.
Not provided
Not provided
Patients need to exclude or confirm a suspected diagnosis of asthma through bronchial challenge testing.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lu Cao, Master | Contact | 13810389517 | caolu301@163.om |
| Name | Affiliation | Role |
|---|---|---|
| Fei Xie, Dr | Chinese PLA General Hospital | Study Director |
Not provided
Study Protocol and research data.
Within 1 year after the publication of research results.
Can be obtained from the main researcher.
Not provided
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |